However, in the cancer microenvironment, cancer cells use immune checkpoints to escape antitumor immune responses, involving pathways mediated by immune checkpoint molecules such as programmed death protein-1 (PD-1), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and various other factors. The gene discussed is CTLA4; the disease is cancer.